Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0091 | ||||
| Gene Name | SLC13A1 | ||||
| Protein Name | Sodium/sulfate cotransporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | NAS1; NASI1; NaSi-1; SLC13A1; Solute carrier family 13 member 1; Na(+)/sulfate cotransporter; hNaSi-1; Renal sodium/sulfate cotransporter | ||||
| DT Family | Divalent Anion:Na(+) Symporter (DASS) Family ; | ||||
| Tissue Specificity | Highly expressed in kidney; not detectable inthe other tissues tested. | ||||
| Function | This transporter sodium/sulfate cotransporter that mediates sulfate reabsorption in the kidney. | ||||
| Endogenous Substrate(s) | Na+; Sfulate; Thiosulfate; Selenium; Anions | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Sulfate | Investigative | Drug Info | Renal and intestinal epithelial cells | Km = 93 microM | [1] |
| References | |||||
| 1 | Na+-sulfate cotransporter SLC13A1. Pflugers Arch. 2014 Jan;466(1):131-7. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.